Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351477	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0"	"Cell type enriched"	"Detected in many"	10	"Late spermatids: 3052.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	84	"Leukemia: 30.1;lymphoma: 34.7;Myeloma: 16.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075570	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 51: Late spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA075570: AB_2732295"	"unprognostic (1.20e-2)"	"prognostic favorable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favorable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favorable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 74.4;Kupffer cells: 76.7;monocytes: 87.2;NK-cells: 81.1;Syncytiotrophoblasts: 74.6;T-cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 92.8;lymphoma: 78.9;Myeloma: 97.0"	"Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"
CAMK4	"CaMK-GR, CaMKIV"	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 70.4;lymphoid tissue: 55.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 361.0;Excitatory neurons: 209.0;Inhibitory neurons: 128.6;Late spermatids: 118.4;Oligodendrocyte precursor cells: 127.6;T-cells: 88.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"basal ganglia: 30.6;cerebellum: 70.4"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3"	"Lineage enriched"	"Detected in many"	23	"T-cells: 33.1"	"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 27.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - Hepatic stellate cells, Skin - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"
CARD11	"BIMP3, CARMA1"	ENSG00000198286	"Caspase recruitment domain family member 11"	Q9BXL7	7	2906142-3043867	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	Immunity		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 34.0;dendritic cells: 36.4;Microglial cells: 48.3;NK-cells: 52.7;T-cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 31.4"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 31.4"	"Cancer enhanced"	"Detected in many"		"lymphoma: 69.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA052984	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA052984: AB_2682005"	"unprognostic (3.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.81e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-8)"	"unprognostic (3.74e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (1.10e-4)"
CARMIL2	"LRRC16C, RLTPR"	ENSG00000159753	"Capping protein regulator and myosin 1 linker 2"	Q6F5E8	16	67644988-67657569	"Disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.4;intestine: 13.4;lymphoid tissue: 21.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 10.8;Bipolar cells: 7.1;dendritic cells: 7.5;Excitatory neurons: 10.5;Horizontal cells: 11.5;Inhibitory neurons: 8.5;T-cells: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Leukemia: 26.9;lymphoma: 40.6;Myeloma: 23.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041402	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA041402: AB_10795591"	"unprognostic (1.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.37e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.90e-5)"	"unprognostic (4.07e-2)"	"unprognostic (5.14e-10)"	"unprognostic (2.25e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.57e-2)"
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 122.1;lymphoid tissue: 135.2"	"Group enriched"	"Detected in many"	10	"NK-cells: 2748.9;T-cells: 2015.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 6788.6;memory CD8 T-cell: 7164.3"	"Group enriched"	"Detected in all"	7	"NK-cells: 2041.1;T-cells: 7164.3"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 18.5;Leukemia: 60.2;lymphoma: 48.9;Myeloma: 36.5;thyroid cancer: 41.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"									CAB078447	Enhanced				"Secreted to blood"	NA	NA	20100000	2900000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB078447: AB_223462"	"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951644-32956349	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 13.0;urinary bladder: 5.4"	"Cell type enriched"	"Detected in some"	4	"T-cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 60.9"	"Lineage enriched"	"Detected in many"	41	"T-cells: 60.9"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 24.0"	"Adipose subcutaneous - T-cells, Breast - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031613	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.63e-3)"	"unprognostic (8.70e-3)"	"unprognostic (2.82e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.59e-7)"	"unprognostic (3.02e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.53e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.40e-1)"
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5"	P51681	3	46370854-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 10.3;Langerhans cells: 41.3;Macrophages: 11.6;T-cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 39.7"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"lymphoma: 1.5;Myeloma: 1.4"	"Lung - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"				"unprognostic (4.32e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.89e-3)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.80e-2)"	"prognostic favorable (9.33e-5)"	"unprognostic (3.38e-3)"	"unprognostic (9.90e-3)"	"unprognostic (7.65e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.14e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.42e-2)"
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 31.4;T-cells: 58.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Cancer enriched"	"Detected in some"	14	"Myeloma: 98.7"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid - T-cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1698.7;dendritic cells: 539.1;granulocytes: 459.9;Hofbauer cells: 485.4;Langerhans cells: 414.6;monocytes: 749.0;NK-cells: 383.4;T-cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 70.9;lymphoma: 194.7"	"Breast - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 148.4;lymphoid tissue: 283.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 361.7;granulocytes: 198.2;Hofbauer cells: 226.3;Kupffer cells: 257.1;Macrophages: 195.3;monocytes: 853.5;NK-cells: 408.9;Schwann cells: 201.6;T-cells: 432.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 207.9;Myeloma: 445.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		2000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"prognostic favorable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favorable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 459.6"	"Cell type enriched"	"Detected in many"	6	"T-cells: 154.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 601.8;naive CD8 T-cell: 1053.9"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1053.9"	"Group enriched"	"Detected in some"	8	"Leukemia: 8.8;Myeloma: 33.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (1.83e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-2)"	"prognostic favorable (7.88e-7)"	"unprognostic (6.23e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.50e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.60e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (7.84e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.33e-2)"
CLEC7A	"CD369, CLECSF12, dectin-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 84.0;lung: 30.9;lymphoid tissue: 44.5"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 188.6;Kupffer cells: 344.7;Langerhans cells: 338.1;Macrophages: 242.9;monocytes: 527.0;Schwann cells: 231.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 249.6"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	12	"Myeloma: 69.4"	"Adipose subcutaneous - Macrophages, Colon - Macrophages, Kidney - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Skin - T-cells, Stomach - Macrophages, Testis - Macrophages"					"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 75: Myeloid cells - Innate immune response"				"unprognostic (1.79e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.40e-1)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.83e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.14e-1)"
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118149	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1175.1;lymphoid tissue: 549.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 1675.4;dendritic cells: 2180.0;monocytes: 1143.3;NK-cells: 1206.4;Schwann cells: 1000.5;T-cells: 1642.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 184.9;lymphoma: 220.2;Myeloma: 144.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"
FYB1	"ADAP, FYB, FYB-120/130, SLAP-130"	ENSG00000082074	"FYN binding protein 1"	O15117	5	39105252-39274528	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 53.0;lymphoid tissue: 112.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 258.6;Kupffer cells: 438.1;Macrophages: 363.0;Microglial cells: 240.8;monocytes: 423.6;NK-cells: 297.7;T-cells: 419.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1670.8"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.0;Leukemia: 31.9"	"Breast - T-cells, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025336, HPA026796, HPA067427"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		6200000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"CAB025336: , HPA026796: AB_10964126, HPA067427: "	"unprognostic (5.65e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (2.40e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.51e-1)"
GBP5		ENSG00000154451	"Guanylate binding protein 5"	Q96PP8	1	89258950-89272804	"Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Antimicrobial, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 73.9"	"Group enriched"	"Detected in many"	4	"monocytes: 38.2;NK-cells: 74.0;T-cells: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 243.8"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 11.7;lymphoma: 11.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid - T-cells"	"Low region specificity"	"Detected in many"							HPA028656	Supported					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA028656: AB_10601471"	"unprognostic (2.72e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.54e-4)"	"prognostic favorable (3.73e-6)"	"unprognostic (8.33e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.71e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.37e-3)"	"prognostic favorable (1.24e-4)"	"unprognostic (3.47e-2)"	"unprognostic (4.16e-1)"	"prognostic unfavorable (5.53e-8)"	"unprognostic (2.75e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.11e-2)"
GPR55		ENSG00000135898	"G protein-coupled receptor 55"	Q9Y2T6	2	230907318-230961066	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.6;lymphoid tissue: 4.4;testis: 4.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 1.8;dendritic cells: 2.2;Excitatory neurons: 2.3;Intestinal goblet cells: 2.4;Langerhans cells: 4.1;Plasma cells: 2.4;T-cells: 6.0"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"basal ganglia: 4.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.9"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Bile duct cancer: 4.8;lymphoma: 4.8"	"Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (9.88e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.24e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.26e-1)"
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 160.8;lymphoid tissue: 229.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 245.3;dendritic cells: 192.4;Hofbauer cells: 386.3;Kupffer cells: 280.3;Langerhans cells: 241.1;Macrophages: 236.3;monocytes: 375.3;NK-cells: 274.2;T-cells: 258.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 54.8;lymphoma: 46.3"	"Lung - Neutrophil_2, Prostate - T-cells, Skin - T-cells, Stomach - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		73000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 62: Granulocytes - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102646-55110252	"Enzymes, Predicted secreted proteins"	Cytolysis	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 68.1"	"Group enriched"	"Detected in many"	29	"NK-cells: 1219.1;T-cells: 707.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	15	"gdT-cell: 941.4;MAIT T-cell: 926.2;memory CD4 T-cell: 250.0;memory CD8 T-cell: 922.7;naive CD8 T-cell: 494.1;NK-cell: 718.8"	"Group enriched"	"Detected in all"	42	"NK-cells: 718.8;T-cells: 941.4"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 89.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA054134, HPA076751"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"HPA054134: AB_2682395, HPA076751: "	"prognostic favorable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2884.6;NK-cells: 1948.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cancer enriched"	"Detected in some"	51	"lymphoma: 378.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"
GZMK	"PRSS, TRYP2"	ENSG00000113088	"Granzyme K"	P49863	5	55024256-55034570	"Enzymes, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 99.6"	"Group enriched"	"Detected in many"	6	"NK-cells: 135.1;T-cells: 259.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 741.6;NK-cell: 505.5"	"Group enriched"	"Detected in many"	199	"NK-cells: 505.5;T-cells: 741.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA063181, HPA065895"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA063181: AB_2684955, HPA065895: "	"prognostic favorable (8.68e-4)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.03e-3)"	"unprognostic (8.13e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.53e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.00e-1)"
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.5;lymphoid tissue: 20.2"	"Cell type enriched"	"Detected in some"	10	"T-cells: 89.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.1"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.1"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.4;lymphoma: 3.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "	"unprognostic (2.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.19e-4)"	"unprognostic (2.35e-5)"	"unprognostic (1.07e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.51e-4)"	"unprognostic (7.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.86e-5)"	"unprognostic (7.05e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.82e-3)"
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 161.5;dendritic cells: 378.3;Langerhans cells: 115.3;monocytes: 150.7;NK-cells: 323.4;T-cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	131	"Leukemia: 92.0;lymphoma: 124.9;Myeloma: 43.3"	"Adipose visceral - T-cells, Colon - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986370-118003037	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 63.6;lymphoid tissue: 73.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 87.4;Extravillous trophoblasts: 106.4;Hofbauer cells: 92.7;Kupffer cells: 118.2;Langerhans cells: 183.8;Macrophages: 134.4;monocytes: 211.2;NK-cells: 106.2;Plasma cells: 95.8;T-cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 29.8;Myeloma: 16.2"	"Adipose subcutaneous - Macrophages, Breast - Macrophages, Skeletal muscle - Macrophages, Skin - T-cells, Stomach - Macrophages, Testis - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	Cytosol	"HPA065647: , HPA069086: "	"unprognostic (1.01e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.27e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (7.70e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.83e-1)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (1.82e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-1)"
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 10.7;monocytes: 34.1;NK-cells: 55.5;Plasma cells: 12.1;T-cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Leukemia: 9.3;lymphoma: 22.4;Myeloma: 27.4"	"Breast - T-cells, Lung - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"HPA074414: AB_2686687"	"unprognostic (7.70e-3)"	"prognostic favorable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"
IL7R	"CD127, IL7RA"	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 183.7"	"Cell type enhanced"	"Detected in many"		"NK-cells: 204.9;Serous glandular cells: 318.6;T-cells: 1261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2"	"Group enriched"	"Detected in all"	33	"NK-cells: 113.2;T-cells: 369.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Colon - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		610000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Group enriched"	"Detected in some"	5	"NK-cells: 26.5;T-cells: 41.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Group enriched"	"Detected in some"	11	"Leukemia: 10.3;lymphoma: 33.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"
NKG7	"GIG1, GMP-17"	ENSG00000105374	"Natural killer cell granule protein 7"	Q16617	19	51371606-51372701	"Predicted intracellular proteins, Predicted membrane proteins"	"Cytolysis, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 602.6;lymphoid tissue: 154.6"	"Cell type enriched"	"Detected in many"	5	"NK-cells: 6101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"gdT-cell: 6827.0;MAIT T-cell: 2871.2;memory CD8 T-cell: 4295.0;naive CD8 T-cell: 3114.2;NK-cell: 4796.8"	"Group enriched"	"Detected in all"	44	"NK-cells: 4796.8;T-cells: 6827.0"	"Group enriched"	"Detected in some"	26	"Leukemia: 62.9;lymphoma: 64.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071454			Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles		"HPA071454: AB_2686399"	"unprognostic (1.56e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (7.42e-6)"	"unprognostic (1.27e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.89e-3)"	"unprognostic (3.39e-1)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (7.62e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.44e-3)"
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.7;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"Schwann cells: 8.3;T-cells: 30.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.0;lymphoma: 1.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: DU4475 - Unknown function"	"Cluster 1: T-cells - Immune response"			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (2.90e-3)"	"unprognostic (4.50e-3)"	"unprognostic (7.78e-2)"	"prognostic favorable (9.44e-5)"	"unprognostic (7.18e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.82e-3)"	"unprognostic (3.75e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.20e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.35e-2)"	"unprognostic (5.06e-3)"
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 506.7;Kupffer cells: 464.5;Macrophages: 507.9;monocytes: 1400.2;NK-cells: 1356.4;T-cells: 1034.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 117.5;lymphoma: 158.9"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"lymphoid tissue: 262.5"	"Group enriched"	"Detected in some"	8	"NK-cells: 146.9;T-cells: 98.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	54	"gdT-cell: 120.2;MAIT T-cell: 162.9;memory CD4 T-cell: 90.4;memory CD8 T-cell: 175.8;naive CD4 T-cell: 91.2;naive CD8 T-cell: 108.3;NK-cell: 162.2;T-reg: 125.3"	"Group enriched"	"Detected in many"	70	"NK-cells: 162.2;T-cells: 175.8"	"Cancer enriched"	"Detected in some"	4	"Leukemia: 38.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA072265			Approved	Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Cytosol		"HPA072265: "	"prognostic favorable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816848	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9"	"Group enriched"	"Detected in many"	4	"NK-cells: 203.0;T-cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"NK-cells: 28.5;T-cells: 66.5"	"Group enriched"	"Detected in many"	6	"Leukemia: 12.8;lymphoma: 31.9;Myeloma: 12.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Fibroblasts, Lung - NK-cells (Lung), Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 1.6"	HPA074482	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA074482: "	"prognostic favorable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.31e-4)"
SIT1	SIT	ENSG00000137078	"Signaling threshold regulating transmembrane adaptor 1"	Q9Y3P8	9	35649295-35650950	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 95.4"	"Group enriched"	"Detected in some"	7	"B-cells: 80.9;dendritic cells: 39.5;Plasma cells: 23.8;T-cells: 80.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	46	"gdT-cell: 119.1;MAIT T-cell: 202.7;memory B-cell: 213.6;memory CD4 T-cell: 249.2;memory CD8 T-cell: 223.4;naive B-cell: 192.1;naive CD4 T-cell: 170.4;naive CD8 T-cell: 169.5;plasmacytoid DC: 203.1;T-reg: 352.4"	"Group enriched"	"Detected in many"	56	"B-cells: 213.6;dendritic cells: 203.1;T-cells: 352.4"	"Group enriched"	"Detected in some"	9	"Leukemia: 22.7;lymphoma: 66.8"	"Colon - T-cells, Lung - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018506	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"HPA018506: AB_2669896"	"unprognostic (4.28e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (8.01e-3)"	"prognostic favorable (1.94e-6)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.75e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (8.17e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.34e-2)"
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646196	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.5;lymphoid tissue: 18.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 29.1;NK-cells: 133.2;T-cells: 52.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 28.8;MAIT T-cell: 24.1;memory CD4 T-cell: 23.8;memory CD8 T-cell: 27.1;naive CD4 T-cell: 21.8;naive CD8 T-cell: 30.5;NK-cell: 39.2;plasmacytoid DC: 48.5;T-reg: 33.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 48.5;NK-cells: 39.2;T-cells: 33.4"	"Cancer enriched"	"Detected in some"	8	"Leukemia: 14.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		No	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 32: Myeloid leukemia - Oxygen transport"	"Cluster 7: NK-cells - Immune response regulation"	"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: AB_2682246, HPA058217: AB_2683641"	"unprognostic (4.16e-3)"	"prognostic favorable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 46.3;Microglial cells: 14.6;Serous glandular cells: 10.9;T-cells: 66.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	19	"Leukemia: 3.6;lymphoma: 3.1;Myeloma: 5.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"
TIGIT	"DKFZp667A205, FLJ39873, VSIG9, VSTM3"	ENSG00000181847	"T cell immunoreceptor with Ig and ITIM domains"	Q495A1	3	114276913-114310288	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 38.7"	"Group enriched"	"Detected in some"	8	"NK-cells: 60.8;T-cells: 79.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 195.5"	"Lineage enriched"	"Detected in many"	11	"T-cells: 195.5"	"Group enriched"	"Detected in some"	7	"lymphoma: 4.5;Myeloma: 1.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"unprognostic (1.24e-2)"	"prognostic favorable (5.43e-4)"	"unprognostic (1.22e-3)"	"unprognostic (2.22e-6)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.96e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.50e-4)"	"unprognostic (3.51e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-8)"	"unprognostic (3.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.18e-3)"
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822770-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 79.8"	"Cell type enriched"	"Detected in some"	11	"T-cells: 118.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 395.1"	"Group enriched"	"Detected in many"	155	"granulocytes: 395.1;T-cells: 313.1"	"Cancer enhanced"	"Detected in some"		"Leukemia: 10.2;lymphoma: 2.5;Myeloma: 2.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Liver - T-cells, Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"
TRBC1	"BV05S1J2.2, TCRBC1"	ENSG00000211751	"T cell receptor beta constant 1"		7	142791694-142793368	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in many"	28	"lymphoid tissue: 1520.1"	"Group enriched"	"Detected in many"	17	"NK-cells: 443.4;T-cells: 435.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 3232.4"	"Lineage enriched"	"Detected in all"	9	"T-cells: 3232.4"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 98.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (1.08e-4)"	"unprognostic (7.96e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.26e-4)"	"unprognostic (1.81e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.76e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.36e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.18e-6)"	"unprognostic (3.98e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.19e-3)"
TRBC2	TCRBC2	ENSG00000211772	"T cell receptor beta constant 2"		7	142801041-142802748	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in many"	5	"intestine: 115.8;lymphoid tissue: 190.2"	"Group enriched"	"Detected in many"	4	"B-cells: 150.2;NK-cells: 264.0;T-cells: 515.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 76.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 76.0"	"Cancer enriched"	"Detected in single"	15	"Leukemia: 12.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"prognostic favorable (8.04e-5)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.19e-3)"	"prognostic favorable (3.42e-8)"	"unprognostic (5.53e-2)"	"prognostic favorable (6.58e-5)"	"unprognostic (3.21e-2)"	"unprognostic (1.30e-2)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.53e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (2.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.09e-3)"
TRGC2	"TCRGC2, TRGC2(2X), TRGC2(3X)"	ENSG00000227191	"T cell receptor gamma constant 2"		7	38239580-38249572	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"bone marrow: 30.5;lymphoid tissue: 34.6;prostate: 23.7"	"Group enriched"	"Detected in some"	4	"NK-cells: 84.0;T-cells: 110.9"	"Cancer enriched"	"Detected in many"	18	"prostate cancer: 26.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 720.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 720.5"	"Group enriched"	"Detected in some"	23	"Leukemia: 42.6;prostate cancer: 13.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Pancreas - T-cells, Prostate - Prostate glandular cells, Skin - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.79e-3)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.62e-4)"	"unprognostic (3.52e-5)"	"unprognostic (3.34e-1)"	"unprognostic (1.46e-3)"	"unprognostic (8.79e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-3)"
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713576-97739862	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;lymphoid tissue: 79.9"	"Group enriched"	"Detected in some"	8	"NK-cells: 143.0;T-cells: 100.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	41	"gdT-cell: 137.4;MAIT T-cell: 93.2;memory CD4 T-cell: 71.7;memory CD8 T-cell: 108.3;naive CD4 T-cell: 50.8;naive CD8 T-cell: 79.8;NK-cell: 112.2;T-reg: 80.1"	"Group enriched"	"Detected in many"	56	"NK-cells: 112.2;T-cells: 137.4"	"Group enriched"	"Detected in some"	5	"Leukemia: 39.9;lymphoma: 13.5;Rhabdoid: 13.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002625, HPA003134"	Enhanced					NA	NA		14000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favorable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favorable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favorable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"
ZNF831	"C20orf174, dJ492J12.1"	ENSG00000124203	"Zinc finger protein 831"	Q5JPB2	20	59123381-59259113	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.4;lymphoid tissue: 6.2"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 19.3;NK-cells: 29.9;T-cells: 53.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 1.2;T-cells: 2.1"	"Cancer enhanced"	"Detected in single"		"Rhabdoid: 2.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	25	"amygdala: 4.6;basal ganglia: 4.1;cerebral cortex: 3.4;hippocampal formation: 5.0;olfactory bulb: 5.4"	HPA016839	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 64: Lymphoma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"HPA016839: AB_1859466"	"unprognostic (2.90e-3)"	"unprognostic (7.70e-6)"	"unprognostic (9.71e-4)"	"unprognostic (1.31e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.00e-5)"	"unprognostic (3.08e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-3)"	"unprognostic (4.31e-1)"	"unprognostic (3.40e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.93e-2)"